BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 21666177)

  • 1. Toward measles elimination in Bahrain--a Middle East country experience.
    Jawad JS; Al-Sayyad AS; Sataih F; Naouri B; Alexander JP
    J Infect Dis; 2011 Jul; 204 Suppl 1():S299-304. PubMed ID: 21666177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress in measles and rubella elimination in Iran.
    Esteghamati A; Gouya MM; Zahraei SM; Dadras MN; Rashidi A; Mahoney F
    Pediatr Infect Dis J; 2007 Dec; 26(12):1137-41. PubMed ID: 18043452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress toward measles and rubella elimination in Egypt.
    El Sayed N; Kandeel N; Barakat I; Moussa I; Alexander JP; Naouri B; Reef SE
    J Infect Dis; 2011 Jul; 204 Suppl 1():S318-24. PubMed ID: 21666180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful control and impending elimination of measles in the Islamic Republic of Iran.
    Zahraei SM; Gouya MM; Azad TM; Soltanshahi R; Sabouri A; Naouri B; Alexander JP
    J Infect Dis; 2011 Jul; 204 Suppl 1():S305-11. PubMed ID: 21666178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supplementary immunization activities to achieve measles elimination: experience of the European Region.
    Khetsuriani N; Deshevoi S; Goel A; Spika J; Martin R; Emiroglu N
    J Infect Dis; 2011 Jul; 204 Suppl 1():S343-52. PubMed ID: 21666183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress toward measles elimination in the Russian Federation, 2003-2009.
    Onishchenko G; Ezhlova E; Gerasimova A; Tsvirkun O; Shulga S; Lipskaya G; Mamayeva T; Aleshkin V; Tikhonova N
    J Infect Dis; 2011 Jul; 204 Suppl 1():S366-72. PubMed ID: 21666186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. South-East Asia Regional update on measles mortality reduction and elimination, 2003-2008.
    O'Connor PM; Liyanage JB; Mach O; Anand A; Ramamurty N; Balakrishnan MR; Singh S
    J Infect Dis; 2011 Jul; 204 Suppl 1():S396-402. PubMed ID: 21666190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
    Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K
    N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress toward measles elimination in the People's Republic of China, 2000-2009.
    Ma C; An Z; Hao L; Cairns KL; Zhang Y; Ma J; Cao L; Wen N; Xu W; Liang X; Yang W; Luo H
    J Infect Dis; 2011 Jul; 204 Suppl 1():S447-54. PubMed ID: 21666198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measles in Mexico, 1941-2001: interruption of endemic transmission and lessons learned.
    Santos JI; Nakamura MA; Godoy MV; Kuri P; Lucas CA; Conyer RT
    J Infect Dis; 2004 May; 189 Suppl 1():S243-50. PubMed ID: 15106118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress toward measles elimination--European Region, 2005--2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Feb; 58(6):142-5. PubMed ID: 19229166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress toward implementation of a second-dose measles immunization requirement for all schoolchildren in the United States.
    Kolasa MS; Klemperer-Johnson S; Papania MJ
    J Infect Dis; 2004 May; 189 Suppl 1():S98-103. PubMed ID: 15106097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress toward measles elimination in the Eastern Mediterranean Region.
    Naouri B; Ahmed H; Bekhit R; Teleb N; Mohsni E; Alexander JP
    J Infect Dis; 2011 Jul; 204 Suppl 1():S289-98. PubMed ID: 21666176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The challenge of achieving measles elimination in the eastern Mediterranean region by 2010.
    Gaafar T; Moshni E; Lievano F
    J Infect Dis; 2003 May; 187 Suppl 1():S164-71. PubMed ID: 12721909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interruption of measles transmission in Gipuzkoa (Basque Country), Spain.
    Cilla G; Basterretxea M; Artieda J; Vicente D; Pérez-Trallero E
    Euro Surveill; 2004 May; 9(5):29-31. PubMed ID: 15208472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measles epidemiology and elimination strategies in Turkey.
    Güriş D; Bayazit Y; Ozdemirer U; Buyurgan V; Yalniz C; Toprak I; Aycan S
    J Infect Dis; 2003 May; 187 Suppl 1():S230-4. PubMed ID: 12721918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The significance of epidemiological studies for progress of measles elimination].
    Mrozek-Budzyn D
    Przegl Epidemiol; 2010; 64(3):361-6. PubMed ID: 20976947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Caribbean experience in maintaining high measles vaccine coverage.
    Irons B; Dobbins JG;
    J Infect Dis; 2011 Jul; 204 Suppl 1():S284-8. PubMed ID: 21666175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approach to verify the status of measles, rubella, and congenital rubella syndrome elimination in Costa Rica.
    Morice A; Avila-Aguero ML; Salas-Peraza D; Soriano A; Castillo-Solórzano C
    J Infect Dis; 2011 Sep; 204 Suppl 2():S690-7. PubMed ID: 21954268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress toward measles elimination in Germany.
    Hellenbrand W; Siedler A; Tischer A; Meyer C; Reiter S; Rasch G; Teichmann D; Santibanez S; Altmann D; Claus H; Kramer M
    J Infect Dis; 2003 May; 187 Suppl 1():S208-16. PubMed ID: 12721915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.